LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization
On Apr. 21, 2020, LabCorpᆴ announced it has received an Emergency Use Authorization (EUA) from the FDA. The EUA permits nasal swab specimens to be collected at home using the Pixel by LabCorpル COVID-19 test home collection kit if recommended by a healthcare provider after completing a COVID-19 questionnaire.
Tags:
Source: LabCorp
Credit: